2025 REMEDi4ALL Hackathon
2025-10-06 14:00 - 2025-10-10 17:00 (Europe/Amsterdam) | Hotel Checkin Montserrat, Carrer Querol, 08293 Collbató, Barcelona, Spain
Are you an early career researcher (ECR) who wants to delve into drug repurposing?

Join us for the second REMEDi4ALL Hackathon, 6-10 October 2025, held at Hotel Checkin Montserrat, near Barcelona, Spain.
The REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.
Who is the Hackathon for?

Students and researchers in the early stages of their career up to 2 years post-doc
Individuals with an interest in drug repurposing
Individuals with an excellent scientific track record
Previous experience in the drug repurposing field will be considered a plus

What will you learn?
The REMEDi4ALL Hackathon aims to teach participants how to:

Use computational tools to generate repurposing candidates suitable for a defined indication
Narrow down potential repurposed drug options tailored to a particular indication
Identify needs and knowledge gaps in a repurposing project, helping to define the path for a drug candidate
Work together with other ECRs to complete a repurposing challenge

Training format

In-person, residential training for 15 participants
Advance registration required
Small teams of early career researchers work on a project throughout the week
Support through lectures and guidance of REMEDi4ALL experts, and external advisers, including patient experts

Interested in learning more? Check out our highlights video from 2024 or explore the Hackathon website within the REMEDi4ALL Repurposing Academy.

Webinar: IP Strategies for Repurposing
2025-11-21 14:00 - 15:30 (Europe/Amsterdam) | Online Event
Discover the value of having an intellectual property (IP) strategy in your repurposing project and how to use this to drive success!
Not sure where to start with intellectual property (IP) in your drug repurposing project? REMEDi4ALL’s Repurposing Academy is here to guide you!
Join us for our upcoming webinar where we will explore the importance of considering IP as part of your broader drug repurposing strategy.
We’ll discuss common challenges you may encounter and key considerations to keep in mind throughout your repurposing project. Additionally, we’ll outline practical steps for securing IP protection for repurposed drugs and show how a strong IP strategy can help drive your project forward.

ProvenConnect REMEDi4ALL Webinar
2025-11-27 13:00 - 14:00 (Europe/Amsterdam) | Online Event
* This is an online event that will take place 1200–1300 UK time (1300-1400 CET) on Zoom. *
REMEDi4ALL is presenting to the TAR Network in a Proven Connect webinar. Speakers Alicia Soler (Lead Scientific Operations at REMEDi4ALL /EATRIS), Heleen van der Meer (Senior programme manager international drug repurposing at ZonMw) and Pan Pantziarka (Director of Drug Repurposing at Anticancer Fund) will present the REMEDi4ALL project and Funder’s Network.

REMEDi4ALL Drug Repurposing Bootcamp for Academics 2026
2026-03-11 08:00 - 2026-03-12 17:00 (Europe/London) | Hinxton Hall, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom
From Hypothesis to Impact: Navigating the Repurposing Pathway
Drug repurposing represents a vital pathway for treatment development, both for patient communities and academic innovators. Finding new uses for existing drugs can provide a more rapid pathway to patient impact, both by reducing the number of steps to a clinical trial and reducing the financial barrier to research.
While the potential of repurposing is huge, the pathway to deliver a repurposed medicine from concept to market remains a hugely challenging one. This is particularly hard for academic researchers to navigate – employing their scientific skill set to the complex and highly regulated world of drug development unsupported can lead to projects quickly becoming mired in challenges or uncertainty.
The REMEDi4ALL Drug Repurposing Bootcamp for Academics, held at the Wellcome Genome Campus in Cambridge, aims to support researchers embarking on this journey. This pilot training course will provide face to face training to explain the full drug repurposing pathway, helping researchers understand the steps involved in turning a repurposing hypothesis into a product capable of delivering real impact to patients.

REMEDi4ALL Funders Network Meets Policy
2026-05-11
REMEDi4ALL Funders Network Meets Policy
As in previous editions, #iDR26 will feature a pre-conference meeting dedicated to the Funders Network on Monday 11 May.
This interactive workshop will bring together research funders and policy-makers to explore opportunities on coordinated funding models and co-funding practices with policy considerations around reimbursement and market access, creating an end-to-end perspective.
Agenda:

12.30-13.30: Lunch
13.30-15.30: Session 1: Push mechanisms (Funders Network & innovative funding models)
15.30-16.00: Break
16.00-18.00: Session 2: Pull mechanisms (Regulatory and pricing & reimbursement policy)
16.00-18.00: Networking drinks

Aim of the Session

Convene research funders and policy representatives to build shared understanding and alignment.
Identify actions funders can take to push drug repurposing forward.
Identify pull mechanisms that policymakers can implement (e.g., incentives for industry, regulatory levers).

Please note that this is an invitation-only event.
Are you a funder who is not yet a member but interested in joining? Contact us at remedi4all@zonmw.nl.

International Drug Repurposing Conference 2026 - #iDR26
2026-05-12 - 2026-05-13 | Maison de la Poste, Brussels, Belgium, Rue Picard 7, Brussels, Belgium
Join iDR26, the International Drug Repurposing Conference, on 12-13 May 2026 in Brussels, Belgium to explore the future of patient-centric medicines repurposing.
From rare diseases and AI-driven drug discovery, to policy, funding and community-led success stories, iDR26 brings together the global drug repurposing community to navigate the next chapter in maximising patient benefit.
Explore the full conference here!

BioMed21 Webinar: Rare Disease Research and Drug Development with NAMs in the EU
2026-06-30 10:30 - 12:30 (Europe/Amsterdam) | Online Event
Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation
Webinar description
BioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar exploring how New Approach Methodologies (NAMs), including advanced human-relevant in vitro models and in silico technologies, are transforming rare disease research and drug development.
The webinar will bring together experts from academia, policy, and biomedical research to discuss innovative approaches ranging from retinal organoids and retina-on-chip systems to computational modelling and AI-driven strategies for therapy development.
Topics will include:

Human-centric strategies for rare disease research
hiPSC-derived organoids and organ-on-chip technologies
In silico modelling and computational approaches
Translational opportunities and challenges for NAMs in therapy development
European research and policy perspectives

Draft agenda

Advancing Human-Centric Strategies for Rare Disease Research: A European Research Policy Perspective
Francesca Pistollato – Humane World for Animals
Human retinal organoids and retina-chip platform for modeling disease and gene therapy
Kevin Achberger – University of Tübingen
Human-Centric In Silico Modeling for Rare Disease Research and Drug Development
Francesco Pappalardo – University of Catania & the COMBINE Group
NAMs in Rare Disease Therapy Development: Where and When Do They Fit?
Manoe Janssen – Radboudumc

📄 BioMed21 Policy Paper: https://biomed21.org/wp-content/uploads/2026/05/RareDiseases_WhitePaper_2026-final.pdf

Register for the webinar here!

Webinar: Understanding the Value of your Repurposed Medicine
2026-07-16 11:00 - 12:30 (Europe/Amsterdam) | Online Event
An introduction to HTA, Early HTA, and patient preference evidence for demonstrating the value of repurposed medicines.

Repurposing has the potential to bring treatments to patients more quickly and efficiently. However, the success of a repurposed medicine depends not only on its clinical effectiveness, but also on demonstrating its value to healthcare decision-makers and ensuring patient access.
Health Technology Assessment (HTA) is the process used to evaluate the value of a health intervention or technology and inform reimbursement and healthcare decision-making.
Join experts from the Syreon Research Institute for an introduction to HTA and Early HTA, and learn how these approaches can support the development, assessment, and value maximisation of repurposed medicines.
The webinar will also explore the role of patient preferences in value assessment, using case studies to showcase the importance of incorporating patient perspectives to strengthen evidence generation and support patient-centred decision-making.
Register for the webinar here!

2026 REMEDi4ALL Hackathon
2026-09-06 14:00 - 2026-09-11 17:00 (Europe/Amsterdam) | Hotel Checkin Montserrat, Carrer Querol, 08293 Collbató, Barcelona, Spain
Are you an early career researcher (ECR) who wants to delve into drug repurposing?

Join us for the third REMEDi4ALL Hackathon, 6-11 September 2026, held at Hotel Checkin Montserrat, near Barcelona, Spain.
The REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.
Who is the Hackathon for?

Students and researchers in the early stages of their career up to 2 years post-doc
Individuals with an interest in drug repurposing
Individuals with an excellent scientific track record
Previous experience in the drug repurposing field will be considered a plus

What will you learn?
The REMEDi4ALL Hackathon aims to teach participants how to:

Use computational tools to generate repurposing candidates suitable for a defined indication
Narrow down potential repurposed drug options tailored to a particular indication
Identify needs and knowledge gaps in a repurposing project, helping to define the path for a drug candidate
Work together with other ECRs to complete a repurposing challenge

Training format

In-person, residential training for 15 participants
Advance registration required
Small teams of early career researchers work on a project throughout the week
Support through lectures and guidance of REMEDi4ALL experts, and external advisers, including patient experts

Interested in learning more? Check out our highlights video from 2025 or explore the Hackathon website within the REMEDi4ALL Repurposing Academy.
Applications open now: apply here
